Karyopharm Therapeutics (KPTI) Stock Chart & Stock Price History → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free KPTI Stock Alerts $0.97 +0.02 (+2.11%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Karyopharm Therapeutics Stock Price Performance5 Day Performance-2.46%1 Month Performance-10.27%3 Month Performance-18.22%6 Month Performance+22.55%Year-To-Date Performance+12.03%1 Year Performance-57.12% Receive KPTI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. KPTI Stock Chart for Sunday, June, 2, 2024 KPTI Chart by TradingView Karyopharm Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.95$0.97+2.20%$1.02$0.931.23 million shs$114.07 million05/30/2024$0.96$0.95-1.47%$0.98$0.92838,898 shs$111.61 million05/29/2024$0.99$0.96-3.14%$1.00$0.912.05 million shs$113.27 million05/28/2024$1.05$0.99-5.38%$1.07$0.981.45 million shs$116.95 million05/27/2024$1.05$1.05$1.10$1.04939,900 shs$123.60 million05/24/2024$1.09$1.05-3.67%$1.10$1.04939,776 shs$123.60 million Get the Latest News and Ratings for KPTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.11$1.09-1.80%$1.13$1.09951,119 shs$128.30 million05/22/2024$1.12$1.11-0.89%$1.16$1.091.06 million shs$130.66 million05/21/2024$1.14$1.12-1.75%$1.19$1.101.22 million shs$131.84 million05/20/2024$1.15$1.14-0.87%$1.19$1.131.23 million shs$134.19 million05/17/2024$1.14$1.15+1.32%$1.19$1.131.56 million shs$135.37 million05/16/2024$1.13$1.14+0.44%$1.15$1.121.95 million shs$133.60 million05/15/2024$1.09$1.13+3.67%$1.17$1.101.84 million shs$133.01 million05/14/2024$1.12$1.09-2.68%$1.19$1.081.49 million shs$128.30 million05/13/2024$1.09$1.12+2.75%$1.15$1.071.05 million shs$131.84 million05/10/2024$1.07$1.09+1.87%$1.11$1.021.13 million shs$126.95 million05/09/2024$1.02$1.07+4.90%$1.11$1.001.50 million shs$124.62 million05/08/2024$1.10$1.02-7.27%$1.20$1.022.64 million shs$118.80 million05/07/2024$1.15$1.10-4.35%$1.20$1.09988,162 shs$128.12 million05/06/2024$1.13$1.15+1.77%$1.19$1.11847,182 shs$133.94 million05/03/2024$1.08$1.13+4.63%$1.19$1.08972,911 shs$131.61 million05/02/2024$1.08$1.08$1.13$1.05974,953 shs$125.79 million05/01/2024$1.03$1.08+4.85%$1.15$1.061.56 million shs$125.79 million04/30/2024$1.10$1.03-6.36%$1.14$1.021.16 million shs$119.96 million04/29/2024$1.06$1.10+3.77%$1.17$1.061.01 million shs$128.12 million04/26/2024$1.06$1.06$1.08$1.02658,707 shs$123.46 million04/25/2024$1.09$1.06-2.75%$1.10$1.03644,533 shs$123.46 million04/24/2024$1.09$1.09$1.15$1.051.20 million shs$125.42 million04/23/2024$1.13$1.09-3.54%$1.17$1.081.59 million shs$125.43 million04/22/2024$1.17$1.13-3.42%$1.20$1.12775,914 shs$130.03 million04/19/2024$1.28$1.17-8.59%$1.31$1.131.44 million shs$134.63 million04/18/2024$1.38$1.28-7.25%$1.42$1.221.31 million shs$147.29 million04/17/2024$1.10$1.38+25.45%$1.38$1.153.15 million shs$158.80 million04/16/2024$1.16$1.10-4.76%$1.20$1.031.17 million shs$126.58 million04/15/2024$1.22$1.16-5.33%$1.22$1.14810,557 shs$132.91 million04/12/2024$1.34$1.22-8.96%$1.35$1.181.39 million shs$140.39 million04/11/2024$1.27$1.34+5.51%$1.34$1.26680,112 shs$154.19 million04/10/2024$1.34$1.27-5.22%$1.34$1.25988,352 shs$146.14 million04/09/2024$1.35$1.34-0.74%$1.41$1.31706,222 shs$154.19 million04/08/2024$1.36$1.35-0.74%$1.39$1.29808,599 shs$155.34 millionWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$1.33$1.36+2.26%$1.41$1.28751,151 shs$156.49 million04/04/2024$1.29$1.33+3.50%$1.44$1.251.49 million shs$153.04 million04/03/2024$1.40$1.29-7.89%$1.39$1.281.12 million shs$147.87 million04/02/2024$1.58$1.40-11.71%$1.56$1.381.07 million shs$160.52 million04/01/2024$1.51$1.58+4.64%$1.65$1.451.47 million shs$181.81 million03/29/2024$1.51$1.51$1.60$1.431.27 million shs$173.76 million03/28/2024$1.48$1.51+2.03%$1.60$1.431.27 million shs$173.76 million03/27/2024$1.39$1.48+6.47%$1.51$1.371.30 million shs$170.30 million03/26/2024$1.39$1.39$1.43$1.38543,979 shs$159.95 million03/25/2024$1.39$1.39$1.45$1.36581,642 shs$159.94 million03/22/2024$1.42$1.39-2.11%$1.44$1.34791,697 shs$159.95 million03/21/2024$1.40$1.42+1.43%$1.47$1.38652,860 shs$163.40 million03/20/2024$1.37$1.40+2.19%$1.42$1.32767,430 shs$161.09 million03/19/2024$1.47$1.37-6.80%$1.50$1.35948,746 shs$157.65 million03/18/2024$1.51$1.47-2.65%$1.62$1.451.37 million shs$169.15 million03/15/2024$1.34$1.51+12.69%$1.55$1.341.72 million shs$173.75 million03/14/2024$1.42$1.34-5.63%$1.45$1.32891,210 shs$154.19 million03/13/2024$1.45$1.42-2.07%$1.53$1.40737,955 shs$163.40 million03/12/2024$1.48$1.45-2.03%$1.58$1.411.02 million shs$166.85 million03/11/2024$1.57$1.48-5.73%$1.64$1.47955,222 shs$170.30 million03/08/2024$1.53$1.57+2.61%$1.70$1.522.13 million shs$180.66 million03/07/2024$1.33$1.53+15.04%$1.61$1.313.14 million shs$176.06 million03/06/2024$1.25$1.33+6.83%$1.40$1.251.27 million shs$153.04 million03/05/2024$1.31$1.25-4.96%$1.34$1.241.07 million shs$143.26 million03/04/2024$1.19$1.31+10.55%$1.32$1.161.59 million shs$150.74 million03/01/2024$1.16$1.19+2.16%$1.27$1.131.70 million shs$135.72 million Related Companies: BioXcel Therapeutics Stock Chart Annexon Stock Chart Verve Therapeutics Stock Chart Erasca Stock Chart Theravance Biopharma Stock Chart Lexicon Pharmaceuticals Stock Chart Esperion Therapeutics Stock Chart Acelyrin Stock Chart FibroBiologics Stock Chart Contineum Therapeutics Stock Chart Receive KPTI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Karyopharm Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KPTI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karyopharm Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.